Abstract
Congenital hypothyroidism remains the leading cause of preventable mental impairment worldwide. Despite ongoing efforts to eradicate iodine deficiency, populations remain at risk for iodine deficiency and consequently, high rates of endemic cretinism. In iodine sufficient populations, sporadic congenital hypothyroidism remains among the most common newborn conditions, which if unrecognized and untreated can lead to irreversible mental impairment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Delange F. Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control. Thyroid 1998; 8 (12): 1185–1192.
Dunn JT. Editorial: What’s Happening to Our Iodine? J Clin Endocrinol Metab 1998; 83: 3398–4000.
Hollowell JG, Staehling NW, Hannon H, et al. Iodine Nutrition in the United States. Trends and Public Health Implications: Iodine Excretion Data from National Health and Nutrition Examination Surveys I and III (1971–1974 and 1988–1994. J Clin Endocrinol Metab 1998; 83: 3401–3408.
Waller DK, Anderson JL, Lorey F, Cunningham GC. Risk factors for congenital hypothyroidism: An investigation of infant’s birth weight, ethnicity, and gender in California, 1990–1998. Teratology 2000; 62 (1): 36–41.
LaFranchi S. Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 1999; 9 (7): 735–40.
Bongers-Schokking JJ, Koot HM, Wiersma D, Verkerk PH, de Muinck Keizer-Schrama SMPF. Influence of timing and dose of thyroid hormone replacement on development in infants with congenital hypothyroidism. J Pediatr 2000; 136: 292–297.
Stoll C, Dott B, Alembik Y, Koehl C. Congenital anomalies associated with congenital hypothyroidism. Ann Genet 1999; 42 (1): 17–20.
Chao T, Wang JR, Hwang B. Congenital hypothyroidism and concomitant anomalies. J Pediatr Endocrinol Metab 1997; 10 (2): 217–221.
Oakley GA, Muir T, Ray M, Girdwood RW, Kennedy R, Donaldson MD. Increased incidence of congenital malformations in children with transient thyroid-stimulating hormone elevation on neonatal screening. J Pediatr 1998; 132 (4): 726–730.
Roberts HE, Moore CA, Fernhoff PM, Brown AL, Khoury MJ. Population study of congenital hypothyroidism and associated birth defects, Atlanta, 1979–1992. Am J Med Genet 1997; 71 (1): 29–32.
Mikai K, Connelly JF, Foley TP Jr, et al. An analysis of the variation of incidences of congenital dysgenetic hypothyroidism in various countries. Endocrinol Jpn 1984; 31 (1): 77–81.
Greig WR, Henderson AS, Boyle JA, McGirr EM, Hutchinson JH. Thyroid dysgenesis in two pairs of monozygotic twins and in a mother and child. J Clin Endocrinol Metab 1966; 26 (12): 1309–1316.
Macchia PE, Felice MD, Lauro RD. Molecular genetics of congenital hypothyroidism. Curr Opin Genet Dev 1999; 9 (3): 289–294.
Macchia PE, Mattei MG, Lapi P, Fenzi G, Di Lauro R. Cloning, chromosomal localization and identification of polymorphisms in the human thyroid transcription factor 2 gene (TITF2). Biochimie 1999; 81 (5): 433–440.
Macchia PE. Recent advances in understanding the molecular basis of primary congenital hypothyroidism. Mol Med Today 2000; 6 (1): 36–42.
Bakker B, Bikker H, Vulsma T, de Randamie JS, Wiedijk BM, De Vijlder JJ. Two decades of screening for congenital hypothyroidism in The Netherlands: TPO gene mutations in total iodide organification defects (an update). J Clin Endocrinol Metab 2000; 85 (10): 3708–3712.
Tatsumi K, Miyai K, Amino N. Genetic basis of congenital hypothyroidism: abnormalities in the TSHbeta gene, the PIT1 gene, and the NIS gene. Clin Chem Lab Med 1998; 36 (8): 659–662
Tonacchera M, Agretti P, Pinchera A, et al. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. J Clin Endocrinol Metab 2000; 85 (3): 1001–1008.
Tiosano D, Pannain S, Vassart G, et al. The hypothyroidism in an inbred kindred with congenital thyroid hormone and glucocorticoid deficiency is due to a mutation producing a truncated thyrotropin receptor. Thyroid 1999; 9 (9): 887–894.
Kosugi S, Bhayana S, Dean HJ. A novel mutation in the sodium/iodide symporter gene in the largest family with iodide transport defect. J Clin Endocrinol Metab 1999; 84 (9): 3248–3253.
Bieberman H, Liesenkotter KP, Emeis M, Oblanden M, Gruters A. Severe congenital hypothyroidism due to a homozygous mutation of the beta TSH gene. Pediatr Res 1999; 46 (2): 170–173.
Gruters A, Kohler B, Wolf A, et al. Screening for mutations of the human thyroid peroxidase gene in patients with congenital hypothyroidism. Exp Clin Cndocrinol Diabetes 1996; 104 (Suppl 4): 121–123.
Macchia PE, Lapi P, Krude H, et al. PAX8 mutations associated with congenital hypothyroidism caused by thyroid dysgenesis. Nat Genet 1998; 19 (1): 83–86.
Fisher DA. The importance of early management in optimizing IQ in infants with congenital hypothyroidism. J Pediatr 2000; 136: 273–274.
Utiger RD. Maternal Hypothyroidism and Fetal Development. N Engl J Med 1999; 341 (8): 601–602.
Haddow JE, Palomaki GE, Allan WC, et al. Thyroid Deficiency During Pregnancy and Subsequent Neuropsychological Development of the Child. N Engl J Med 1999; 341 (8): 549–555.
Yasuda T, Ohnishi H, Wataki K, Minagawa M, Minamitani K, Niimi H. Outcome of a baby born from a mother with acquired juvenile hypothyroidism having undetectable thyroid hormone concentrations. J Clin Endocrinol Metab 1999; 84 (8): 2630–2632.
Jagannathan NR, Tandon N, Raghunathan P, Kochupillai N. Reversal of abnormalities of myelination by thyroxine therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Brain Res Dev Brain Res 1998; 109 (2): 179–186.
Masuno M, Imaizumi K, Okada T, et al. Young-Simpson syndrome: further delineation of a distinct syndrome with congenital hypothyroidism, congenital heart defects, facial dysmorphism, and mental retardation. Am J Med Genet 1999; 84 (1): 8–11.
Siragusa V, Boffelli S, Weber G, et al. Brain magnetic resonance imaging in congenital hypothyroid infants at diagnosis. Thyroid 1997; 7 (5): 761–764.
Price DA, Ehrlich RM, Walfish PG. Congenital hypothyroidism. Clinical and laboratory characteristics in infants detected by neonatal screening. Arch Dis Child 1981; 56 (11): 845–851.
Larsson A, Ljunggren JG, Ekman K, Nilsson A, Olin P, Bodegard G. Screening for congenital hypothyroidism. II. Clinical findings in infants with positive screening tests. Acta Paediatr Scand 1981; 70 (2): 147–53.
Alm J, Hagenfeldt L, Larsson A, Lundberg K. Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) 1984; 289 (6453): 1171–1175.
Devos H, Rodd C, Gagne N, Laframboise R, Van Vliet G. A search for the possible molecular mechanisms of thyroid dysgenesis: sex ratios and associated malformations. J Clin Endocrinol Metab 1999; 84 (7): 2502–2506.
Willnow S, Kiess W, Butenandt O, et al. Endocrine disorders in septo-optic dysplasia (De Morsier syndrome)—evaluation and follow up of 18 patients. Eur J Pediatr 1996; 155 (3): 179–184.
Aynaci FM, Orhan F, Celep F, Karaguzel A. Frequency of cardiovascular and gastrointestinal malformations, leukemia and hypothyroidism in children with Down syndrome in Trabzon, Turkey. Turk J Pediatr 1998; 40 (1): 103–109.
Fort P, Lifshitz F, Bellisario R, et al. Abnormalities of thyroid function in infants with Down syndrome. J Pediatr 1984; 104 (4): 545–549.
Bucci I, Napolitano G, Giuliani C, et al. Zinc sulfate supplementation improves thyroid function in hypozincemic Down children. Biol trace Elem Res 1999; 67 (3): 257–268.
Selikowitz M. A five-year longitudinal study of thyroid function in children with Down syndrome. Dev Med Child Neurol 1993; 35 (5): 396–401.
Cutler AT, Benezra-Obeiter R, Brink SJ. Thyroid function in young children with Down syndrome. Am J Dis Child 1986; 140 (5): 479–483.
Rooney S, Walsh E. Prevalence of abnormal thyroid function tests in a Down’s syndrome population. Ir J Med Sci 1997; 166 (2): 80–82.
Pueschel SM, Jackson IM, Giesswein P, Dean MK, Pezzullo JC. Thyroid function in Down syndrome. Res Dev Disabil 1991; 12 (3): 287–296.
Guthrie R, Susi A. 1963. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics 32: 338–343.
Dussault JH, Laberge C. A new method for detection of hypothyroidism in the newborn. Clin Res 1972; 20: 918.
Klein AH, Agustin AV, Foley TP Jr. Successful screening for congenital hypothyroidism. Lancet 1974; 2: 77.
Hsiao PH, Chiu YN, Tsai WY, Su SC, Lee JS, Soong WT. Intellectual outcomes of patients with congenital hypothyroidism not detected by neonatal screening. J Formos Med Assoc 1999; 98 (7): 512–515.
Fisher DA, Dussault JH, Foley TP Jr, et al. Screening for congenital hypothyroidism: results of screening one million North American infants. J Pediatr 1979; 94 (5): 700–705.
Barden HS, Kessel R. The costs and benefits of screening for congenital hypothyroidism in Wisconsin. Soc Biol 1984; 31 (3–4): 185–200.
Larson C, Hermos RJ, Rojas D, Mitchell ML. Rising Incidence of Congenital Hypothyroidism Detected by Primary T4 Screening in Massachusetts. Presented June 1999, International Society for Neonatal Screening, Stockholm.
Hanna CE, Krainz PL, Skeels MR, et al. Detection of congenital hypopituitary hypothyroidism: Ten year experience in The Northwest Regional Screening Program. J Pediatr 1986; 109 (6): 959–964.
Hunter MK, Mandel SH, Sesser DE, Miyahira RS, Rien L, Skeels MR, LaFranchi SH. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: Results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998; 132 (1): 70–74.
Mandel S, Hanna C, Boston B, Sesser D, LaFranchi S. Thyroxine-binding globulin deficiency detected by newborn screening. J Pediatr 1993; 122 (2): 227–230.
Wang ST, Pizzolato S, Demshar HP. Diagnostic effectiveness of TSH screening and of T4 with secondary TSH screening for newborn congenital hypothyroidism. Clin Chim Acta 1998;22: 274(2):151–158.
Dussault JH, Morissette J. Higher sensitivity of primary thyrotropin in screening for congenital hypothyroidism: a myth? J Clin Endocrinol Metab 1983; 56 (4): 849–852.
Gruters A, Liesenkotter KP, Zapico M, Jenner A, Dutting C, Pfeiffer E, Lehmkuhl U. Results of the screening program for congenital hypothyroidism in Berlin (1978–1995). Exp Clin Endocrinol Diabetes 1997; 105(Suppl 4): 28–3 1.
Gruneiro-Papendieck L, Prieto L, Chiesa A, Bengolea S, Bossi G, Bergada C. Usefulness of thyroxine and free thyroxine filter paper measurements in neonatal screening for congenital hypothyroidism of preterm babies. J Med Screen 2000; 7 (2): 78–81.
Zurakowski D, DiCanzio J, Majzoub JA. Pediatric Reference Intervals for Serum Thyroxine, Triiodothyronine, Thyrotropin, and Free Thyroxine. Clin Chem 1999; 45 (7): 1087–1091.
Dussault JH, Morissette J, Laberge C. Blood thyroxine concentration is lower in low-birth-weight infants. Clin Chem 1979; 25 (12): 2047–2049.
Kok JH, Hart G, Endert E, Koppe JG, de Vijlder JJ. Normal ranges of T4 screening values in low birthweight infants. Arch Dis Child 1983; 58 (3): 190–194.
Fisher DA. Thyroid function in very low birthweight infants. Clin Endocrinol 1997; 47: 1–3.
Levy HL. Is early discharge a problem for newborn screening? Early Hospital Discharge: Impact on Newborn Screening, Ed. K Pass, HL Levy, 1995, pp. 23–30. Atlanta: CORN.
Hermos R, Rojas D, Delaney A, et al. Rising Mean Thyroxine (T4) Screening in Massachusetts Newborns. Presented at National Newborn Screening Conference 1999.
Sfakianakis GN, Ezuddin SH, Sanchez JE, Eidson M, Cleveland W. Pertechnetate scintigraphy in primary hypothyroidism. J Nucl Med 1999; 40 (5): 799–804.
Newborn Screening for Congenital Hypothyroidism: Recommended Guidelines. Pediatrics 1993; 91 (6): 1203–1209.
Mandel SJ, Hermos RJ, Lason CA, Prigozhana AB, Rojas DA, Mitchell ML. Late onset hypothyroidism and the very low birthweight infant. Thyroid 2000; 10 (8): 693–695.
Brown RS, Bellisario RL, Botero D, et al. Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies. J Clin Endocrinol Metab 1996;81(3):1147–115 1.
Hack M, Friedman H, Fanaroff AA. Outcomes of Extremely Low Birth Weight Infants. Pediatrics 1996; 98 (5): 931–937.
Halsey CL, Collin MF, Anderson CL. Extremely Low-birth-weight Children and Their Peers: A Comparison of School-age Outcomes. Arch Pediatr Adolesc Med 1996; 150: 790–794.
Reuss ML, Leviton A, Paneth N, Susser M. Thyroxine Values from Newborn Screening of 919 Infants Born before 29 Weeks’ Gestation. Am J Public Health 1997; 87: 1693–1697.
Paul DA, Leef KH, Stefano JL, Bartoshesky L. Low Serum Thyroxine on Initial Newborn Screening Is Associated With Intraventricular Hemorrhage and Death in Very Low Birth Weight Infants. Pediatrics 1998; 101 (5): 903–907.
Van Wassenaer AG, Kok JH, de Vijlder JJ, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks’ gestation. N Engl J Med 1997; 336 (1): 21–26.
Fisher DA. Hypothyroxinemia in premature infants: is thyroxine treatment necessary? Thyroid 1999; 9 (7): 715–720.
Bettendorf M, Schmidt KG, Grulich-Henn J, Ulmer HE, Heinrich UE. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomized, placebo-controlled study. Lancet 2000; 356 (9229): 529–534.
Toft AD. Thyroid hormone replacement-one hormone or two? N Engl J Med 1999; 340 (6): 469–470.
Bunevicius R, Kazanavicius G, Zalinkevicius R, Prange AJ. Effects of thyroxine as compared with thyroxine plus triodothyronine in patients with hypothyroidism. N Engl J Med 1999; 340 (6): 424–429.
Ohmori M, Harada K, Tsuruoka S, Sugimoto K, Kobayashi E, Fujimura A. Levothyroxine-induced liver dysfunction in a primary hypothyroid patient. Endocrinol J 1999; 46 (4): 579–583.
Revised guidelines for neonatal screening programmes for primary congenital hypothyroidism. Working Group on Neonatal Screening of the European Society for Paediatric Endocrinology. Horm Res 1999; 52 (1): 49–52
Bargagna S, Canepa G, Costagli C, et al. Neuropsychological follow-up in early-treated congenital hypothyroidism: a problem-oriented approach. Thyroid 2000; 10 (3): 243–249.
Bargagna S, Dinetti D, Pinchera A, et al. School attainments in children with congenital hypothyroidism detected by neonatal screening and treated early in life. Eur J Endocrinol 1999;140(5):407–4 13.
Barnes ND. Screening for congenital hypothyroidism: the first decade. Arch Dis Child 1985; 60 (6): 587–592.
New England Congenital Hypothyroidism Collaborative. Neonatal hypothyroidism screening: status of patients at 6 years of age. J Pediatr 1985; 107 (6): 915–919
Rovet JF, Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics 2000; 105 (3 Pt 1): 515–522.
Rovet JF. Long-term neuropsychological sequelae of early-treated congenital hypothyroidism: effects in adolescence. Acta Paediatr Suppl 1999; 88 (432): 88–95.
Rovet JF. Congenital hypothyroidism: long-term outcome. Thyroid 1999; 9 (7): 741–748.
Salerno M, Militerni R, Di Maio S, Bravaccio C, Gasparini N, Tenore A. Eur J Endocrinol 1999; 141 (2): 105–10.
Garcia M, Calzada-Leon R, Perez J, et al. Longitudinal assessment of L-T4 therapy for congenital hypothyroidism: differences between athyreosis vs ectopia and delayed vs normal bone age. J Pediatr Endocrinol Metab 2000; 13 (1): 63–69.
Report of the New England Regional Screening Program and the New England Congenital Hypothyroidism Collaborative. Pitfalls in screening for neonatal hypothyroidism. Pediatrics 1982; 70 (1): 16–20.
New England Congenital Hypothyroidism Collaborative. Effects of neonatal screening for hypothyroidism: prevention of mental retardation by treatment before clinical manifestations. Lancet 1981; 2 (8255): 1095–1098.
Mitchell ML, Larsen PR, Levy HL, Bennett AJ, Madoff MA. Screening for congenital hypothyroidism. Results in the newborn population of New England. JAMA 1978; 239 (22): 2348–2351.
Davy T, Daneman D, Walfish PG, Ehrlich RM. Congenital hypothyropidism. The effect of stopping treatment at 3 years of age. Am J Dis Child 1985; 139 (10): 1028–1030.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Larson, C.A. (2003). Congenital Hypothyroidism. In: Radovick, S., MacGillivray, M.H. (eds) Pediatric Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-336-1_16
Download citation
DOI: https://doi.org/10.1007/978-1-59259-336-1_16
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-268-1
Online ISBN: 978-1-59259-336-1
eBook Packages: Springer Book Archive